Table 3.

Change in stair climb test at day 113 or end of study compared with baseline

	Placebo	Enobosarm 1 mg	Enobosarm 3 mg
Stair climb time (s)
N	36	32	28
Mean (SD)	0·20 (2·98)	–1·63 (3·39)	–2·22 (7·05)
Median (range)	–0·14 (–4·61 to 14·54)	–0·84 (–12·67 to 5·56)	–0·46 (–31·01 to 5·06)
p value*	0·26	0·0019	0·0065
Stair climb power (watts)†
N	36	31	28
Mean (SD)	2·21 (39·30)	14·26 (53·77)	16·81 (31·08)
Median (range)	11·34 (–156·36 to 56·37)	19·93 (–235·34 to 110·14)	12·84 (–77·74 to 93·15)
p value*	0·11	0·0008	0·0006

These analyses were done for patients for whom efficacy data were evaluable; no adjustments have been made for missing data.

^*p values are from an exact Wilcoxon signed rank test.

^†Power=(9·8 [m/s²]× stair height [m] × weight [kg])/stair climb time (s).